US Congress in impasse over new Covid-19 relief aid

  • 📰 STForeignDesk
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 71%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

WASHINGTON - Prospects looked bleak Tuesday for congressional approval of billions of dollars in new emergency aid to fight Covid-19, and White House officials said they had already scaled back plan

s to purchase treatments and reimburse doctors who care for uninsured patients because pandemic relief money has run out.Until now, both the Trump and Biden administrations have been able to secure emergency money for coronavirus relief with no strings attached.

But the No 2 Republican in the Senate, Mr John Thune of South Dakota, told reporters that a spending bill would be a"much heavier lift" if the administration did not come up with some way to pay for it by repurposing existing funds. But Speaker Nancy Pelosi stripped the Covid-19 money from the broader bill in response to pushback from governors and rank-and-file Democrats, who complained that US$7 billion of it was going to be taken back from states.

Senator John Thune , Republican of South Dakota, said House progressives “torpedoed” a chance for relief funds. PHOTO: AFP Unlike most of his colleagues, Mr Blunt said he would be open to appropriating new funds without taking the money from other programmes. He said he spoke to Mr Zients Tuesday and supported buying more therapeutics, tests and vaccines - but with a catch.

As Republicans and the White House sparred over funding, the Senate health committee on Tuesday approved a broad package of pandemic preparedness legislation, sending it to the full Senate for a vote.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US, EU, India, South Africa reach compromise on Covid-19 vaccine IP waiver text2022.4 ( Expected ) = Melatonin as adjunctive therapy in patients admitted to the Covid-19
Source: STForeignDesk - 🏆 4. / 71 Read more »

Husband of US V-P Kamala Harris tests positive for Covid-19straits_times When he tells her that he is positive then She will laugh loudly for this
Source: STForeignDesk - 🏆 4. / 71 Read more »

US will run out of key COVID-19 treatments without more funds, White House saysWASHINGTON: The US government will run out of supplies of COVID-19 treatments known as monoclonal antibodies as soon as late May and will have to scale back plans to get more unless Congress provides more funding, the White House said on Tuesday (Mar 15). Raising the alarm about depleted funding for t Presently you're telecasting wrong info on Gujarat massacres in 2002 after Godhra train burning.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer seeks US FDA authorisation for fourth Covid-19 vaccine shot for seniors
Source: STForeignDesk - 🏆 4. / 71 Read more »

Pfizer-BioNTech seek US OK for second COVID-19 booster for 65 and olderPfizer and its German partner BioNTech SE on Tuesday (Mar 15) filed an application with US regulators seeking emergency use authorisation for a second booster shot of their COVID-19 vaccine for people aged 65 and older. The submission to the US Food and Drug Administration includes data collected Over two years and still considered “EUA” with no clear solution? What emergency? lol. A very convenient excuse to keep it going & potentially making it into a racketeering fraud. Esp when the vaccine is failing badly and designed for Alpha strain not Omicron.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer-BioNTech seek US approval of second COVID-19 booster for those aged 65 and olderPfizer and BioNTech announced Tuesday (Mar 15) they had formally asked the United States drug regulator for emergency approval of a second booster shot of their COVID-19 vaccine for people aged 65 and older. The companies said in a press statement that their request is based off two Israeli st
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »